LSL Pharma Group Inc Financial Overview
LSL Pharma Group Inc's market cap is currently C$43.64M. The company's EPS TTM is C$-0.01; its P/E ratio is 14.88; LSL Pharma Group Inc is scheduled to report earnings on November 19, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
